Neogen Retained Earnings (Accumulated Deficit) 2010-2025 | NEOG

Neogen retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Neogen Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024 $556
2023 $565
2022 $588
2021 $540
2020 $479
2019 $419
2018 $359
2017 $296
2016 $252
2015 $216
2014 $182
2013 $154
2012 $127
2011 $104
2010 $81
2009 $64
Neogen Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2025-02-28 $76
2024-11-30 $87
2024-08-31 $543
2024-05-31 $556
2024-02-29 $561
2023-11-30 $563
2023-08-31 $567
2023-05-31 $565
2023-02-28 $559
2022-11-30 $551
2022-08-31 $593
2022-05-31 $588
2022-02-28 $573
2021-11-30 $568
2021-08-31 $557
2021-05-31 $540
2021-02-28 $524
2020-11-30 $510
2020-08-31 $495
2020-05-31 $479
2020-02-29 $462
2019-11-30 $450
2019-08-31 $434
2019-05-31 $419
2019-02-28 $403
2018-11-30 $390
2018-08-31 $374
2018-05-31 $359
2018-02-28 $341
2017-11-30 $325
2017-08-31 $308
2017-05-31 $296
2017-02-28 $283
2016-11-30 $273
2016-08-31 $262
2016-05-31 $252
2016-02-29 $242
2015-11-30 $234
2015-08-31 $225
2015-05-31 $216
2015-02-28 $206
2014-11-30 $199
2014-08-31 $191
2014-05-31 $182
2014-02-28 $175
2013-11-30 $168
2013-08-31 $162
2013-05-31 $154
2013-02-28 $147
2012-11-30 $140
2012-08-31 $133
2012-05-31 $127
2012-02-29 $121
2011-11-30 $115
2011-08-31 $110
2011-05-31 $104
2011-02-28 $98
2010-11-30 $93
2010-08-31 $87
2010-05-31 $81
2010-02-28 $76
2009-11-30 $73
2009-08-31 $68
2009-05-31 $64
2009-02-28 $60
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.424B $0.924B
Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.007B 27.90
Boston Scientific (BSX) United States $155.135B 38.84
Stryker (SYK) United States $149.698B 31.30
EssilorLuxottica (ESLOY) France $129.877B 0.00
Medtronic (MDT) Ireland $110.440B 16.12
Lonza Group Ag (LZAGY) Switzerland $48.984B 0.00
Haleon (HLN) United Kingdom $48.101B 27.36
ResMed (RMD) United States $36.449B 27.38
GE HealthCare Technologies (GEHC) United States $33.384B 15.85
Agilent Technologies (A) United States $32.046B 21.17
Terumo (TRUMY) Japan $27.153B 35.27
Koninklijke Philips (PHG) Netherlands $22.822B 16.41
Insulet (PODD) United States $22.662B 88.96
Zimmer Biomet Holdings (ZBH) United States $19.138B 12.29
Baxter (BAX) United States $15.929B 11.89
Smith & Nephew SNATS (SNN) United Kingdom $12.591B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $6.618B 23.03
Lantheus Holdings (LNTH) United States $5.520B 13.92
Prestige Consumer Healthcare (PBH) United States $4.305B 19.23
Perrigo (PRGO) Ireland $3.614B 9.16
Haemonetics (HAE) United States $3.485B 15.18
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.459B 25.51
Envista Holdings (NVST) United States $3.066B 25.48
QuidelOrtho (QDEL) United States $2.234B 15.36
GN Store Nord (GNNDY) Denmark $2.150B 17.81
LeMaitre Vascular (LMAT) United States $1.882B 42.07
AtriCure (ATRC) United States $1.599B 0.00
AdaptHealth (AHCO) United States $1.220B 12.38
Kestra Medical Technologies (KMTS) United States $1.220B 0.00
Green Thumb Industries (GTBIF) United States $1.209B 27.19
BioLife Solutions (BLFS) United States $1.045B 0.00
InMode (INMD) Israel $1.023B 9.37
Phibro Animal Health (PAHC) United States $0.966B 12.35
Evolus (EOLS) United States $0.645B 0.00
CeriBell (CBLL) United States $0.636B 0.00
Curaleaf Holdings (CURLF) Canada $0.586B 0.00
Owens & Minor (OMI) United States $0.548B 4.54
Valneva SE (VALN) France $0.516B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.499B 0.00
Tilray Brands (TLRY) Canada $0.443B 0.00
Capricor Therapeutics (CAPR) United States $0.437B 0.00
Surmodics (SRDX) United States $0.401B 0.00
Cresco Labs (CRLBF) United States $0.354B 0.00
SNDL (SNDL) Canada $0.336B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.95
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Aurora Cannabis (ACB) Canada $0.279B 49.60
Sanara MedTech (SMTI) United States $0.274B 0.00
Verano Holdings (VRNOF) United States $0.271B 0.00
Sanuwave Health (SNWV) United States $0.268B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.47
Cerus (CERS) United States $0.247B 0.00
Canopy Growth (CGC) Canada $0.246B 0.00
ZimVie (ZIMV) United States $0.242B 11.00
Omeros (OMER) United States $0.230B 0.00
Biote (BTMD) United States $0.220B 6.18
Brainsway (BWAY) Israel $0.188B 49.90
High Tide (HITI) Canada $0.187B 0.00
OraSure Technologies (OSUR) United States $0.184B 0.00
Utah Medical Products (UTMD) United States $0.180B 14.51
Quanterix (QTRX) United States $0.175B 0.00
Organigram Global (OGI) Canada $0.166B 0.00
TriSalus Life Sciences (TLSI) United States $0.165B 0.00
FitLife Brands (FTLF) United States $0.136B 16.72
Jin Medical (ZJYL) China $0.129B 0.00
TerrAscend (TSNDF) Canada $0.128B 0.00
Exagen (XGN) United States $0.122B 0.00
MacroGenics (MGNX) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Fonar (FONR) United States $0.084B 10.83
Veru (VERU) United States $0.075B 0.00
Agape ATP (ATPC) $0.075B 0.00
InterCure (INCR) Israel $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.067B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Quipt Home Medical (QIPT) United States $0.065B 0.00
United Health Products (UEEC) United States $0.064B 0.00
Apyx Medical (APYX) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.052B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Modular Medical (MODD) United States $0.040B 0.00
United-Guardian (UG) United States $0.038B 13.00
Rockwell Medical (RMTI) United States $0.033B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Nephros (NEPH) United States $0.023B 30.57
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.019B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00